Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/1997
05/09/1997WO1997016171A1 Membrane-fusible liposome with the use of recombinant sendai virus
05/09/1997WO1997016166A1 Skin care preparation and method
05/09/1997WO1997016078A1 Aromatic granulated material
05/09/1997CA2236207A1 Improved process and composition for therapeutic cisplatin (cddp)
05/09/1997CA2236175A1 New technology for wet granulation
05/07/1997EP0771849A2 Polymer blends containing polyoxaesters
05/07/1997EP0771832A2 Blends of absorbable polyoxaesters containing amines and/or amido groups
05/07/1997EP0771566A1 Stabilization of colloidal systems by the formation of ionic lipid-polysaccharide complexes
05/07/1997EP0771559A1 Cosmetic and pharmaceutical emulsions
05/07/1997EP0771558A1 Cosmetic and pharmaceutical emulsions
05/07/1997EP0771528A1 Bovine teat dip formulation
05/07/1997EP0771339A1 Moisture barrier film coating composition, method, and coated form
05/07/1997EP0771207A1 Use of magnesium hydroxide as a stool softener
05/07/1997EP0771205A2 Novel clinical uses of polyene macrolides
05/07/1997EP0771191A1 Immunological activity of rhamnolipids
05/07/1997EP0771190A1 Lock and key micelles
05/07/1997EP0771189A1 Inhalation composition
05/07/1997EP0756479A4 Gentle anti-acne composition
05/07/1997EP0703778B1 Methods and apparatus for making liposomes
05/07/1997EP0686024B1 Thickening mixture based on guar gum or non-ionic cellulose and a cross-linked polymer, and cosmetic or dermatological hair- or skin-care composition containing said mixture
05/07/1997EP0684973B1 Process for the preparation of a water-dispersible carotenoid preparation in powder form
05/07/1997EP0670715B1 Oral delivery composition forming a microemulsion
05/07/1997EP0662820B1 Compositions for treatmewnt of inflamed tissues
05/07/1997EP0660676B1 Novel compositions
05/07/1997EP0652774B1 Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
05/07/1997EP0599942B1 A method of making biocompatible capsules containing cells
05/07/1997EP0587659B1 Pharmaceutical carrier
05/07/1997EP0565522B1 Dried, rotary disc fatty acid microencapsulated bacteria
05/07/1997EP0542969B1 Biodegradable particulate vector and method of synthesis
05/07/1997EP0419563B1 Time release protein
05/07/1997DE19541326A1 Wasserlösliche oder wasserdispergierbare Polyurethane mit endständigen Säuregruppen, ihre Herstellung und ihre Verwendung Water-soluble or water-dispersible polyurethanes having terminal acid groups, their preparation and their use
05/07/1997DE19541260A1 Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut Therapeutic composition for transdermal administration of drugs through the skin
05/07/1997DE19540446A1 Tablet or capsule for encouraging waking in persons having difficulty to wake up
05/07/1997CN1149259A Stabilized homogenous suspensions AS computed tomography contrast agents
05/07/1997CN1148986A New skin preparation composition
05/07/1997CN1148984A Process for preparing pharmaceutical formulation containing insulin analog
05/07/1997CN1148977A Rescription of Yiganning capsule for hepatitis B and its process
05/07/1997CN1148967A Ointment
05/07/1997CN1148965A Paste for parotid gland and preparation thereof
05/07/1997CN1148964A Tongniaoling for diuresis
05/07/1997CN1148962A Prescription of oral liquid for regulating blood sugar and blood lipid and preparation thereof
05/07/1997CN1148961A Pellet for generation of semen
05/07/1997CN1148960A Preparation of capsule and instant powder of extracts of wood frog oil
05/07/1997CN1148959A Oral liquid of growth factor of animal thymus
05/07/1997CN1148957A Aqueously soluble powder preparation of taxinol and its preparing method
05/07/1997CN1148956A Method of production of sustained-release preparation
05/07/1997CA2189520A1 Blends of absorbable polyoxaesters containing amines and/or amido groups
05/06/1997US5627233 Biocompatability
05/06/1997US5627216 Medicinal ointment for hemorrhoid and skin care
05/06/1997US5627212 Esters of L-carnitine and acyl L-carnitine with hydoxy acids for producing pharmcaeutical compositions for treating dermatoses
05/06/1997US5627171 Synergistic antimetastasis agents
05/06/1997US5627159 Enhancement of lipid cationic transfections in the presence of serum
05/06/1997US5627153 Anti-fungal methods and materials
05/06/1997US5626880 Infusion preparation
05/06/1997US5626879 Terfenadine oral granules
05/06/1997US5626878 Reduction of electrostatic forces between magnesium trisilicate adsorbates
05/06/1997US5626877 Polymer-based drug delivery system
05/06/1997US5626876 Floating system for oral therapy
05/06/1997US5626875 Stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation
05/06/1997US5626874 Time release tablets with cores of active compounds and barrier layers with gels or polymers
05/06/1997US5626873 Emulsions
05/06/1997US5626871 Receptacles with cellulose and starch powders for allergies, asthma, bronchitis or lung diseases
05/06/1997US5626870 Accurately controlled particle size
05/06/1997US5626869 Pharmaceutical composition containing a defined lipid system
05/06/1997US5626868 Amphoteric and nonionic surfactants with lipid vesicles
05/06/1997US5626867 Liposome for cytotoxic agents
05/06/1997US5626866 Drug-containing adhesive composite transdermal delivery device
05/06/1997US5626865 Enzyme-orthokeratology
05/06/1997US5626864 Preparation of colloidal aqueous solutions of active substances of low solubility
05/06/1997US5626863 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
05/06/1997US5626862 Drug delivery from polymer matrices by release from matrix by degradation of polymer
05/06/1997US5626856 Cosmetic delivery vehicles and related compositions
05/06/1997US5626838 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
05/06/1997US5626832 Iodinated contrast agent
05/06/1997US5626751 Filter unit and high-pressure sizing apparatus
05/06/1997US5626561 Implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein
05/06/1997CA2044132C Transdermal acrylic multipolymer drug delivery system
05/06/1997CA2032394C Multiple encapsulated sweetener delivery system and method of preparation
05/06/1997CA2023867C Sorbitol coated comestible and method of preparation
05/02/1997EP0770627A1 Composition and methods using nitroxides to avoid oxygen toxicity
05/02/1997EP0770391A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in pharmaceutical compositions
05/02/1997EP0770390A1 Nasally administrable compositions containing physiologically active peptides
05/02/1997EP0770387A1 Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic
05/02/1997EP0770386A1 Lanperisone formulation
05/02/1997EP0770384A1 Solid, anhydrous, pharmaceutical compositions for vaginal use
05/02/1997EP0770383A1 Ophthalmic cromolyn gel preparation
05/02/1997EP0770382A1 Cosmetic and/or pharmaceutical emulsions
05/02/1997EP0770381A1 Support and composition containing it together with a stabilised cosmetic or dermatologic agent
05/02/1997EP0770140A1 Nucleic acid containing composition, preparation and uses of same
05/02/1997EP0770053A1 Positive photoactive compounds based on 2,6-dinitrobenzyl groups
05/02/1997EP0769997A1 Method and apparatus for forming compression dosage units within the product package
05/02/1997EP0769996A1 Method and apparatus for retaining a formed compression dosage unit within a die cavity
05/02/1997EP0769995A1 Method and apparatus for forming compression dosage units
05/02/1997EP0769973A1 Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
05/02/1997EP0769965A1 Aqueous risperidone formulations
05/02/1997EP0769961A1 Attenuation of wound healing processes
05/02/1997EP0769960A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
05/02/1997EP0769953A1 Pharmaceutical compositions comprising co-dried sucralfate gel and polyalcohol
05/02/1997EP0769949A1 Hydromorphone therapy
05/02/1997EP0769948A1 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension